MRP ₹52
(Inclusive of all Taxes)
₹7.8 Cashback (15%)
Extra 15% Off with Bank Offers
Composition :
ACYCLOVIR-3%W/W
Manufacturer/Marketer :
Chethana Pharmaceuticals
Consume Type :
Ophthalmic
Expires on or after :
Return Policy :
Not Returnable
Secure Payment
Trusted by 8 Crore Indians
Genuine Products
Disclaimer
While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.
Alcohol
Pregnancy
Breast Feeding
Driving
Liver
Kidney
Children
Product Substitutes
Drug-Drug Interactions
Drug-Drug Interactions
Login/Sign Up
How does the drug interact with Virapt 3% Eye Ointment 5 gm:
Co-administration of Cidofovir with Acyclovir can increase the risk of kidney problems.
How to manage the interaction:
Taking Virapt 3% Eye Ointment 5 gm with Cidofovir is not recommended, please consult your doctor before taking it. You should consult a doctor if you experience vomiting, irregular urination, sudden weight gain or loss, swelling, shortness of breath, muscle cramps, weakness, and palpitations. Do not stop using any medications without talking to a doctor.
Co-administration of Cidofovir with Acyclovir can increase the risk of kidney problems.
How to manage the interaction:
Taking Virapt 3% Eye Ointment 5 gm with Cidofovir is not recommended, please consult your doctor before taking it. You should consult a doctor if you experience vomiting, irregular urination, sudden weight gain or loss, swelling, shortness of breath, muscle cramps, weakness, and palpitations. Do not stop using any medications without talking to a doctor.
How does the drug interact with Virapt 3% Eye Ointment 5 gm:
Coadministration of Virapt 3% Eye Ointment 5 gm with Tenofovir Disoproxil may increase the risk or severity of kidney disorder.
How to manage the interaction:
Coadministration of Virapt 3% Eye Ointment 5 gm with Tenofovir disoproxil can result in an interaction, it can be taken when your doctor has advised it. Contact a doctor immediately if you experience decreased or increased urine output, sudden weight gain or loss, swelling, or shortness of breath. Do not discontinue any medications without consulting a doctor.
Coadministration of Virapt 3% Eye Ointment 5 gm with Tenofovir Disoproxil may increase the risk or severity of kidney disorder.
How to manage the interaction:
Coadministration of Virapt 3% Eye Ointment 5 gm with Tenofovir disoproxil can result in an interaction, it can be taken when your doctor has advised it. Contact a doctor immediately if you experience decreased or increased urine output, sudden weight gain or loss, swelling, or shortness of breath. Do not discontinue any medications without consulting a doctor.
Severe
How does the drug interact with Virapt 3% Eye Ointment 5 gm:
Concomitant use of Virapt 3% Eye Ointment 5 gm with Tizanidine can increase the risk of developing low blood pressure.
How to manage the interaction:
Coadministration of Virapt 3% Eye Ointment 5 gm with Tizanidine can result in an interaction, but it can be taken if your doctor has advised it. Contact a doctor immediately if you experience signs such as dizziness, excessive sweating, or palpitations. Do not discontinue any medications without consulting a doctor.
Concomitant use of Virapt 3% Eye Ointment 5 gm with Tizanidine can increase the risk of developing low blood pressure.
How to manage the interaction:
Coadministration of Virapt 3% Eye Ointment 5 gm with Tizanidine can result in an interaction, but it can be taken if your doctor has advised it. Contact a doctor immediately if you experience signs such as dizziness, excessive sweating, or palpitations. Do not discontinue any medications without consulting a doctor.
Severe
How does the drug interact with Virapt 3% Eye Ointment 5 gm:
Coadministration of Virapt 3% Eye Ointment 5 gm with Amphotericin B can increase the risk or severity of kidney disorder.
How to manage the interaction:
Taking Virapt 3% Eye Ointment 5 gm with Amphotericin b together can result in an interaction, it can be taken if a doctor has advised it. Consult a doctor if you experience irregular urination, muscle ache, shortness if breath, or palpitations. Do not discontinue any medications without consulting a doctor.
Coadministration of Virapt 3% Eye Ointment 5 gm with Amphotericin B can increase the risk or severity of kidney disorder.
How to manage the interaction:
Taking Virapt 3% Eye Ointment 5 gm with Amphotericin b together can result in an interaction, it can be taken if a doctor has advised it. Consult a doctor if you experience irregular urination, muscle ache, shortness if breath, or palpitations. Do not discontinue any medications without consulting a doctor.
AciclovirMetrizamide
Severe
How does the drug interact with Virapt 3% Eye Ointment 5 gm:
Coadministration of Metrizamide in contrast with Virapt 3% Eye Ointment 5 gm may increase the risk or severity of kidney disorder.
How to manage the interaction:
Before undergoing any imaging procedure, let your doctor know you are on Virapt 3% Eye Ointment 5 gm treatment. Look out for signs such as vomiting, increased or decreased urination, sudden weight gain or loss, swelling, shortness of breath, muscle cramps, or weakness. Consult the doctor immediately.
Coadministration of Metrizamide in contrast with Virapt 3% Eye Ointment 5 gm may increase the risk or severity of kidney disorder.
How to manage the interaction:
Before undergoing any imaging procedure, let your doctor know you are on Virapt 3% Eye Ointment 5 gm treatment. Look out for signs such as vomiting, increased or decreased urination, sudden weight gain or loss, swelling, shortness of breath, muscle cramps, or weakness. Consult the doctor immediately.
Severe
How does the drug interact with Virapt 3% Eye Ointment 5 gm:
Coadministration of Virapt 3% Eye Ointment 5 gm with Everolimus may increase the risk or severity of kidney injury.
How to manage the interaction:
Taking Virapt 3% Eye Ointment 5 gm with Everolimus together can result in an interaction, it can be taken if a doctor has advised it. Contact a doctor immediately if you experience vomiting, irregular urination, sudden weight gain or loss, swelling, breathing difficulty, muscle pains, dizziness, or palpitations. Do not discontinue any medications without consulting a doctor.
Coadministration of Virapt 3% Eye Ointment 5 gm with Everolimus may increase the risk or severity of kidney injury.
How to manage the interaction:
Taking Virapt 3% Eye Ointment 5 gm with Everolimus together can result in an interaction, it can be taken if a doctor has advised it. Contact a doctor immediately if you experience vomiting, irregular urination, sudden weight gain or loss, swelling, breathing difficulty, muscle pains, dizziness, or palpitations. Do not discontinue any medications without consulting a doctor.
How does the drug interact with Virapt 3% Eye Ointment 5 gm:
Coadministration of Virapt 3% Eye Ointment 5 gm with Tenofovir alafenamide may increase the risk or severity of kidney injury.
How to manage the interaction:
Taking Virapt 3% Eye Ointment 5 gm with tenofovir alafenamide can result in an interaction. However, if the benefits outweigh the risks, your doctor will prescribe them. Contact a doctor immediately if you experience symptoms such as decreased or increased urine output, sudden weight gain or loss, swelling, or shortness of breath. Do not discontinue any medication without consulting your doctor.
Coadministration of Virapt 3% Eye Ointment 5 gm with Tenofovir alafenamide may increase the risk or severity of kidney injury.
How to manage the interaction:
Taking Virapt 3% Eye Ointment 5 gm with tenofovir alafenamide can result in an interaction. However, if the benefits outweigh the risks, your doctor will prescribe them. Contact a doctor immediately if you experience symptoms such as decreased or increased urine output, sudden weight gain or loss, swelling, or shortness of breath. Do not discontinue any medication without consulting your doctor.
AciclovirIodamide
Severe
How does the drug interact with Virapt 3% Eye Ointment 5 gm:
Coadministration of Iodamide contrast with Virapt 3% Eye Ointment 5 gm may increase the risk or severity of kidney injury.
How to manage the interaction:
Before undergoing any imaging procedure let your doctor know you are on Virapt 3% Eye Ointment 5 gm treatment.
Coadministration of Iodamide contrast with Virapt 3% Eye Ointment 5 gm may increase the risk or severity of kidney injury.
How to manage the interaction:
Before undergoing any imaging procedure let your doctor know you are on Virapt 3% Eye Ointment 5 gm treatment.
How does the drug interact with Virapt 3% Eye Ointment 5 gm:
Coadministration of Virapt 3% Eye Ointment 5 gm with Sirolimus may increase the risk or severity of kidney injury.
How to manage the interaction:
Taking Virapt 3% Eye Ointment 5 gm with Sirolimus can result in an interaction, it can be taken if your doctor has advised it. However, if you experience vomiting, a decrease in hunger, irregular urine, weight gain or loss, swelling, difficulty breathing, muscle pain, or weakness, consult a doctor.
Coadministration of Virapt 3% Eye Ointment 5 gm with Sirolimus may increase the risk or severity of kidney injury.
How to manage the interaction:
Taking Virapt 3% Eye Ointment 5 gm with Sirolimus can result in an interaction, it can be taken if your doctor has advised it. However, if you experience vomiting, a decrease in hunger, irregular urine, weight gain or loss, swelling, difficulty breathing, muscle pain, or weakness, consult a doctor.
Severe
How does the drug interact with Virapt 3% Eye Ointment 5 gm:
Co-administration of Virapt 3% Eye Ointment 5 gm with tacrolimus may increase the risk or severity of kidney problems.
How to manage the interaction:
Coadministration of Virapt 3% Eye Ointment 5 gm with Tacrolimus can result in an interaction, it can be taken if your doctor has advised it. Contact a doctor immediately if you experience signs such as decreased or increased urine output, sudden weight gain or loss, swelling, or shortness of breath. Do not discontinue any medications without first consulting a doctor.
Co-administration of Virapt 3% Eye Ointment 5 gm with tacrolimus may increase the risk or severity of kidney problems.
How to manage the interaction:
Coadministration of Virapt 3% Eye Ointment 5 gm with Tacrolimus can result in an interaction, it can be taken if your doctor has advised it. Contact a doctor immediately if you experience signs such as decreased or increased urine output, sudden weight gain or loss, swelling, or shortness of breath. Do not discontinue any medications without first consulting a doctor.
Drug-Food Interactions
No Drug - Food interactions found in our database. Some may be unknown. Consult your doctor for what to avoid during medication.
Drug-Food Interactions
Login/Sign Up
Drug-Diseases Interactions
ACYCLOVIR-3%W/WOther disorders of kidney and ureter, not elsewhere classified
Severe
ACYCLOVIR-3%W/WVolume depletion
Moderate
Drug-Diseases Interactions
Login/Sign Up
ACYCLOVIR-3%W/WOther disorders of kidney and ureter, not elsewhere classified
Severe
How does the disease interact with Virapt 3% Eye Ointment 5 gm:
Acyclovir should be used with caution to patients who have impaired kidney function. In patients with moderate to severe renal impairment, dosage modifications are advised.
How to manage the interaction:
The use of Virapt 3% Eye Ointment 5 gm in kidney disease patients is not advised as it may increase the severity of kidney disease. Your doctor may adjust the dosing according to the severity of your kidney disease.
Acyclovir should be used with caution to patients who have impaired kidney function. In patients with moderate to severe renal impairment, dosage modifications are advised.
How to manage the interaction:
The use of Virapt 3% Eye Ointment 5 gm in kidney disease patients is not advised as it may increase the severity of kidney disease. Your doctor may adjust the dosing according to the severity of your kidney disease.
ACYCLOVIR-3%W/WVolume depletion
Moderate
How does the disease interact with Virapt 3% Eye Ointment 5 gm:
Patients who are dehydrated may be more susceptible to nephrotoxicity from using acyclovir. Acyclovir should be infused intravenously over the course of an hour, along with appropriate hydration.
How to manage the interaction:
Virapt 3% Eye Ointment 5 gm is excreted through the kidneys, dehydration may cause damage to kidney functions. Virapt 3% Eye Ointment 5 gm infusion over an hour is recommended in dehydrated patients. Urine output should be monitored.
Patients who are dehydrated may be more susceptible to nephrotoxicity from using acyclovir. Acyclovir should be infused intravenously over the course of an hour, along with appropriate hydration.
How to manage the interaction:
Virapt 3% Eye Ointment 5 gm is excreted through the kidneys, dehydration may cause damage to kidney functions. Virapt 3% Eye Ointment 5 gm infusion over an hour is recommended in dehydrated patients. Urine output should be monitored.
ACYCLOVIR-3%W/WCare involving dialysis
Moderate
How does the disease interact with Virapt 3% Eye Ointment 5 gm:
Hemodialysis effectively removes acyclovir from the body. Following 6 hours of dialysis, it has been demonstrated that plasma levels of acyclovir decrease by 60%. After hemodialysis, acyclovir should be administered. If not, a second dosage might be administered following each hemodialysis session.
How to manage the interaction:
Patients undergoing hemodialysis should be given Virapt 3% Eye Ointment 5 gm after completing hemodialysis as hemodialysis removes 60% of Virapt 3% Eye Ointment 5 gm from the body.
Hemodialysis effectively removes acyclovir from the body. Following 6 hours of dialysis, it has been demonstrated that plasma levels of acyclovir decrease by 60%. After hemodialysis, acyclovir should be administered. If not, a second dosage might be administered following each hemodialysis session.
How to manage the interaction:
Patients undergoing hemodialysis should be given Virapt 3% Eye Ointment 5 gm after completing hemodialysis as hemodialysis removes 60% of Virapt 3% Eye Ointment 5 gm from the body.
All Substitutes & Brand Comparisons
RX
Ocuvir Eye Ointment 5 gm
FDC Ltd
₹61
(₹10.98/ 1gm)
17% COSTLIER
Have a query?